The global eubiotics market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. More Info:- https://www.imarcgroup.com/eubiotics-market

1. Global Eubiotics Market
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Eubiotics Market:
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast
2024-2032," the global eubiotics market size reached US$ 4.6 Billion in 2023.
Eubiotics are innovative feed additives that support animal performance and
welfare by promoting gut health. Some commonly used eubiotics include
organic acids, probiotics, prebiotics, phytogenics or essential oils, and gut
health enzymes. They act as natural digestive stimulants and assist in
enhancing digestive health, nutrient absorption, and strengthening immunity in
poultry, swine, livestock, and aquatic animals.
They aid in maintaining a healthy balance of microbiota in the gastrointestinal
tract such as bacteria, archaea, protists, and fungi. They also play an
essential role in immunologic, hormonal, and metabolic homeostasis. As a
result, eubiotics are gaining immense traction as an alternative to antibiotics in
the feed.
Request for a PDF sample of this report:
https://www.imarcgroup.com/eubiotics -market/requestsample

4. Report Description
Global Eubiotics Market Trends:
The rapid industrialization of the livestock industry due to the escalating demand for poultry meat and dairy
products represents the primary factor driving the market growth. Moreover, the rising concerns regarding meat
quality among consumers is another major growth-inducing factor. Besides this, the growing prevalence of
livestock diseases has strengthened the product demand as consumption of eubiotics-based feed provides
essential nutrients and health and medicinal benefits to livestock, such as prevention and timely treatment of
chronic diseases.
Additionally, there has been a rise in the usage of eubiotics as a substitute for antibiotic growth promoters
(AGPs) in animals and livestock. In line with this, the increasing domestication of animals as pets, especially in
developed nations, has accelerated the product adoption rate. Furthermore, several key players are utilizing
innovative microbiological solutions to develop novel product variants with targeted results and easy digestibility.
Along with this, the implementation of stringent laws and regulations discouraging the usage of antibiotics by
governing agencies of various countries has propelled market growth. Other factors, including the surging
awareness regarding feed quality and safety, shifting consumer preferences toward protein-rich diets, inflating
prices of natural feed grades, and technological advancements, are also providing a positive thrust to the market
growth.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/eubiotics-market

5. Report
Segmentation
Breakup by Product:
• Probiotics
• Prebiotics
• Organic Acids
• Essential Oils
• Others
Breakup by Form:
• Liquid
• Solid
Breakup by Application:
• Gut Health
• Immunity
• Yield
• Others

6. Report
Segmentation
Breakup by End-Use:
• Cattle Feed
• Poultry Feed
• Swine Feed
• Aquafeed
• Others
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Advanced Bionutrition Corp.
• Behn Meyer Holding AG
• Beneo Gmbh (Südzucker AG)
• Calpis Co. Ltd. (Asahi Group Holdings Ltd.)
• Koninklijke DSM N.V.
• DuPont de Nemours Inc.
• Kemin Industries Inc.
• Lallemand Inc.
• Lesaffre
• Novus International Inc. (Mitsui & Co. Ltd.)
• UAS Laboratories LLC (Chr. Hansen Holding
A/S).

8. Key Questions
Answered in
the Report
How has the global eubiotics market performed so far, and
how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the
global eubiotics market?
What is the impact of each driver, restraint, and opportunity
on the global eubiotics market?
What are the key regional markets?
Which countries represent the most attractive eubiotics
market?
What is the breakup of the market based on the product?
Which is the most attractive product in the eubiotics market?
What is the breakup of the market based on the form?
Which is the most attractive form in the eubiotics market?

9. Key Questions
Answered in
the Report
What is the breakup of the market based on the application?
What is the most attractive application in the eubiotics
market?
What is the breakup of the market based on the end-use?
Which is the most attractive end-use segment in the eubiotics
market?
What is the breakup of the market based on the Region?
Which region represents the most attractive eubiotics market?
What is the competitive structure of the market?
Who are the key players/companies in the global eubiotics
market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Eubiotics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Probiotics
6.1.1 Mark et Trends
6.1.2 Mark et Forecast
6.2 Prebiotics
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
6.3 Organic Acids
6.3.1 Mark et Trends
6.3.2 Mark et Forecast

11. Table of
Contents
6.4 Essential Oils
6.4.1 Mark et Trends
6.4.2 Mark et Forecast
6.5 Others
6.5.1 Mark et Trends
6.5.2 Mark et Forecast
7 Market Breakup by Form
7.1 Liquid
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Solid
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
8 Market Breakup by Application
8.1 Gut Health
8.1.1 Mark et Trends
8.1.2 Mark et Forecast
8.2 Immunity
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
8.3 Yield
8.3.1 Mark et Trends
8.3.2 Mark et Forecast
8.4 Others
8.4.1 Mark et Trends
8.4.2 Mark et Forecast
9 Market Breakup by End Use
9.1 Cattle Feed
9.1.1 Mark et Trends
For more information, visit :
https://www.imarcgroup.com/eubiotics -market/toc

12. Partial List of Clients

13. Partial List of Clients

14. Disclaimer
© 2024 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

15. Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
sales@imarcgroup.com
Stay With Us: